Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...

CRISPR–Cas, a bacterial defence system that recognizes and slashes specific sequences in viral genomes, gave scientists the power to delete or edit genes with remarkable precision.

University of California, Berkeley biochemist Jennifer Doudna won the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for their pioneering work on CRISPR-Cas9. This revolutionary ...

Doudna earned the 2020 Nobel Prize in Chemistry for co-developing CRISPR Cas-9 genome engineering technology. The FDA-approved therapy is the first of its kind to treat sickle cell disease.

Nobel Laureate Jennifer A. Doudna, PhD, kicked off Fred Hutch Cancer Center's inaugural President's Seminar Series last week. She spoke about CRISPR, the gene-editing tool she helped pioneer, and how ...

This revolutionary technique, which brought its inventors, Jennifer Doudna and Emmanuelle Charpentier, the Nobel Prize in Chemistry in 2020, enables scientists to accurately target and modify ...

That appears to be the case for engineering T cells with CRISPR-Cas9, too, as new research from the lab of the technology’s co-creator Jennifer Doudna, Ph.D., shows.

Owen T. Tuck, a graduate student in Jennifer Doudna’s lab at the University of California, Berkeley, thinks that the enzymes used for genome editing and engineering (such as Cas9 and Cas12 ...